小儿咳喘灵口服液联合易坦静治疗支气管肺炎临床研究  

Clinical Study on Xiao'er Kechuanling Oral Solution Combined with Yitanjing forBronchopneumonia

作　　者：张秀丽 ZHANG Xiuli

机构地区：[1]湖州师范学院附属第一人民医院小儿科,浙江湖州313000

出　　处：《新中医》2021年第4期178-181,共4页New Chinese Medicine

摘　　要：目的:观察小儿咳喘灵口服液联合易坦静治疗支气管肺炎的临床效果。方法:将支气管肺炎患儿108例随机分为观察组与对照组,各54例。2组均给予优质护理干预,对照组应用易坦静治疗,观察组在对照组的基础上联合小儿咳喘灵口服液治疗。比较2组临床总有效率、第1秒用力呼气容积(FEV1)、用力肺活量(FVC)、呼吸气流量分值(PEF)、病情改善用时、不良反应情况。结果:观察组总有效率为96.30%,对照组为74.07%,2组比较,差异有统计学意义(P<0.05)。治疗后,2组FEV1、FVC、PEF均较治疗前升高(P<0.05),且观察组上述指标均高于对照组(P<0.05)。观察组患儿退热、咳嗽停止、肺部湿啰音消失、喘息消失用时均短于对照组,差异有统计学意义(P<0.05)。观察组不良反应发生率为3.70%,对照组为5.56%,2组比较,差异无统计学意义(P>0.05)。结论:小儿咳喘灵口服液联合易坦静治疗支气管肺炎患儿疗效显著,结合优质护理干预可有效改善患儿肺功能及临床症状。Objective:To observe the clinical effect of Xiao'er Kechuanling oral solution combined with Yitanjing for bronchopneumonia.Methods:A total of 108 cases of children with bronchopneumonia were randomly divided into the observation group and the control group,54 cases in each group.Both groups were given high-quality nursing intervention;the control group was treated with Yitanjing,and the observation group was additionally treated with Xiao'er Kechuanling oral solution based on the treatment of the control group.The total effective rates,forced expiratory volume in the first second(FEV1),forced vital capacity(FVC),peak expiratory flow(PEF),the time for disease improvement,and adverse reactions in the two groups were compared.Results:The total effective rate was 96.30%in the observation group and 74.07%in the control group,the difference being significant(P<0.05).After treatment,FEV1,FVC and PEF in the two groups were allincreased when compared with those before treatment(P<0.05), and the above indexes in the observation group were allhigher than those in the control group(P<0.05). The antipyretic time,the stopping time of coughing and the disappearancetime of moist rales and wheezing in the observation group were shorter than those in the control group,the difference beingsignificant(P<0.05). The incidence of adverse reactions was 3.70% in the observation group and 5.56% in the control group,there being no significant difference between the two groups(P>0.05). Conclusion:The therapy of Xiao'er Kechuanling oralsolution combined with Yitanjing has significant curative effect in treating children with bronchopneumonia. The combiningintervention of high-quality nursing can effectively improve their lung function and clinical symptoms.

关 键 词：支气管肺炎 小儿咳喘灵口服液 易坦静 优质护理 肺功能 

分 类 号：R563.12[医药卫生—呼吸系统] R473.72[医药卫生—内科学]